Clinical and economic outcomes of patients with brain metastases based on symptoms: An argument for routine brain screening of those treated with upfront radiosurgery

Cancer

Volumn 120, Issue 3, 2014, Pages 433-441

  Lester, Scott C ^a   Taksler, Glen B ^b   Kuremsky, J Griff ^a   Lucas, John T ^a   Ayala Peacock, Diandra N ^a   Randolph II, David M ^a   Bourland, J Daniel ^a   Laxton, Adrian W ^a   Tatter, Stephen B ^a   Chan, Michael D ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain metastases; cost saving; economics; stereotactic radiosurgery; surveillance magnetic resonance imaging; symptoms

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DEATH; BRAIN DYSFUNCTION; BRAIN METASTASIS; CANCER MORTALITY; CANCER SURVIVAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRANIOTOMY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OVERALL SURVIVAL; PRIORITY JOURNAL; REHABILITATION CARE; RETREATMENT; SALVAGE THERAPY; SEX DIFFERENCE; STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; SYMPTOM;

BRAIN METASTASES; COST SAVING; ECONOMICS; STEREOTACTIC RADIOSURGERY; SURVEILLANCE MAGNETIC RESONANCE IMAGING; SYMPTOMS;

AGED; BRAIN NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84892948031     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28422     Document Type: Article

References (19)

1. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006; 295: 2483-2491.
2. National Comprehensive Cancer Network. Central Nervous System Cancers. Version 2. 2013. Available at: http://www.nccn.org/professionals/physician-gls/ pdf/cns.pdf. Accessed June 30, 2013.
3. Lutterbach J, Cyron D, Henne K, Ostertag CB,. Radiosurgery followed by planned observation in patients with 1 to 3 brain metastases. Neurosurgery. 2008; 62: 776-784.
4. Sheehan JP, Yen CP, Nguyen J, Rainey JA, Dassoulas K, Schlesinger DJ,. Timing and risk factors for new brain metastasis formation in patients initially treated only with Gamma Knife surgery. J Neurosurg. 2011; 114: 763-768.
5. Korones DN, Butterfield R, Meyers SP, Constine LS,. The role of surveillance magnetic resonance imaging (MRI) scanning in detecting recurrent brain tumors in asymptomatic children. J Neurooncol. 2001; 53: 33-38.
6. Gaspar LE, Scott C, Murray K, Curran W,. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000; 47: 1001-1006.
7. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998; 280: 1485-1489.
8. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000; 47: 291-298.
9. Howlader N, Noone AM, Krapcho M, et al. eds. SEER Cancer Statistics Review, 1975-2010 [based on November 2012 SEER data submission, posted to the SEER web site 2013.]. Bethesda, MD: National Cancer Institute; 2013.
10. Harris S, Chan MD, Lovato JF, et al. Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer [serial online]. Int J Radiat Oncol Biol Phys. 2012; 83: e53-e59.
11. Jensen CA, Chan MD, McCoy TP, et al. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg. 2011; 114: 1585-1591.
12. Niwinska A, Tacikowska M, Murawska M,. The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death. Int J Radiat Oncol Biol Phys. 2010; 77: 1134-1139.
13. Majhail NS, Chander S, Metha VS, Julka PK, Ganesh T, Rath GK,. Factors influencing early complications following Gamma Knife radiosurgery. A prospective study. Stereotact Funct Neurosurg. 2001; 76: 36-46.
14. Elliott RE, Rush S, Morsi A, et al. Neurological complications and symptom resolution following Gamma Knife surgery for brain metastases 2 cm or smaller in relation to eloquent cortices. J Neurosurg. 2010; 113: 53-64.
15. Colice GL, Birkmeyer JD, Black WC, Littenberg B, Silvestri G,. Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest. 1995; 108: 1264-1271.
16. Kovanlikaya A, Karabay N, Cakmakci H, Uysal K, Olgun N, Ergor G,. Surveillance imaging and cost effectivity in pediatric brain tumors. Eur J Radiol. 2003; 47: 188-192.
17. Mehta M, Noyes W, Craig B, et al. A cost effectiveness and cost-utility analysis of radiosurgery vs resection for single-brain metastases. Int J Radiat Oncol Biol Phys. 1997; 39: 445-454.
18. Rutigliano MH, Lunsford LD, Kondziolka D, Strauss MJ, Khanna V, Green M,. The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery. 1995; 37: 445-453.
19. Vuong DA, Rades D, van Eck ATC, Horstmann GA, Busse R,. Comparing the cost-effectiveness of 2 brain metastasis treatment modalities from a payer's perspective: stereotactic radiosurgery versus surgical resection. Clin Neurol Neurosurg. 2013; 115: 276-284.